Cefazolin and Muscle function loss - a phase IV clinical study of FDA data

Summary:

Muscle function loss is reported as a side effect among people who take Cefazolin (cefazolin sodium), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Neurontin, and have Agranulocytosis.

The phase IV clinical study analyzes which people have Muscle function loss when taking Cefazolin. It is created by eHealthMe based on reports of 15,127 people who have side effects when taking Cefazolin from the FDA, and is updated regularly.

What is Cefazolin?

Cefazolin has active ingredients of cefazolin sodium. It is often used in infection. eHealthMe is studying from 15,157 Cefazolin users. Check the latest studies of Cefazolin.

What is Muscle function loss?

Muscle function loss is found to be associated with 1,000 drugs and 1,520 conditions by eHealthMe. Check the latest studies of Muscle function loss.

On Jul, 10, 2026

15,127 people reported to have side effects when taking Cefazolin.
Among them, 26 people (0.17%) have Muscle function loss.

Could Cefazolin cause Muscle function loss?

Among these 26 people:

How long have people been on Cefazolin when they have Muscle function loss? *

What is the gender of people who have Muscle function loss when taking Cefazolin? *

female: 88.46 %
male: 11.54 %

What is the age of people who have Muscle function loss when taking Cefazolin? *

What are other drugs people take besides Cefazolin? *

What are other side effects people have besides Muscle function loss? *

Weakness: 15 people, 57.69%
Fall: 13 people, 50.00%
Heart Rate Increased: 12 people, 46.15%
Hypoaesthesia (reduced sense of touch or sensation): 12 people, 46.15%
Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect): 11 people, 42.31%
Dizziness: 11 people, 42.31%
Chest Pain: 11 people, 42.31%
Stress And Anxiety: 11 people, 42.31%
Drug Withdrawal Syndrome (interfere with normal social, occupational, or other functioning. are not due to another medical condition, drug use, or discontinuation): 11 people, 42.31%
Memory Loss: 11 people, 42.31%

What are the existing conditions these people have? *

Neuropathy Peripheral (surface nerve damage): 7 people, 26.92%
Fibromyalgia (a long-term condition which causes pain all over the body): 7 people, 26.92%
Breast Cancer: 7 people, 26.92%
Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 7 people, 26.92%
Pain: 4 people, 15.38%
Urticaria (rash of round, red welts on the skin that itch intensely): 1 person, 3.85%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 3.85%
Rashes (redness): 1 person, 3.85%
Nervous System Disorder (a general class of medical conditions affecting the nervous system): 1 person, 3.85%
Hypotonia (low muscle tone): 1 person, 3.85%

* Approximation only. Some reports may have incomplete information.

Do you take Cefazolin and have Muscle function loss?

- Check whether Muscle function loss is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Cefazolin:

Cefazolin (15,157 reports)

Browse all side effects of Cefazolin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Muscle function loss:

Muscle function loss (1,000 drugs)

Browse all the conditions that are associated with Muscle function loss:

Muscle function loss (1,520 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on cefazolin sodium (the active ingredients of Cefazolin) and Cefazolin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.